Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: December 2, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 210019

Email this page to a colleague

« Back to Dashboard

NDA 210019 describes IVERMECTIN, which is a drug marketed by Padagis Israel, Teva Pharms Usa, Taro, and Edenbridge Pharms, and is included in four NDAs. It is available from six suppliers. Additional details are available on the IVERMECTIN profile page.

The generic ingredient in IVERMECTIN is ivermectin. There are five drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the ivermectin profile page.
Summary for 210019
Applicant:Teva Pharms Usa
Formulation / Manufacturing:see details
Pharmacology for NDA: 210019
Medical Subject Heading (MeSH) Categories for 210019
Suppliers and Packaging for NDA: 210019
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
IVERMECTIN ivermectin CREAM;TOPICAL 210019 ANDA Actavis Pharma, Inc. 0591-4052 0591-4052-89 1 TUBE in 1 CARTON (0591-4052-89) > 45 g in 1 TUBE
IVERMECTIN ivermectin CREAM;TOPICAL 210019 ANDA Bryant Ranch Prepack 63629-8754 63629-8754-1 1 TUBE in 1 CARTON (63629-8754-1) > 45 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength1%
Approval Date:Sep 13, 2019TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.